Literature DB >> 32575031

Prenatal antibiotic exposure and risk of attention-deficit/hyperactivity disorder: a population-based cohort study.

Amani F Hamad1, Silvia Alessi-Severini1, Salaheddin Mahmud1, Marni Brownell1, I Fan Kuo2.   

Abstract

BACKGROUND: Abnormal microbiota composition induced by prenatal exposure to antibiotics has been proposed as a potential contributor to the development of attention-deficit/hyperactivity disorder (ADHD). We examined the association between prenatal antibiotic exposure and risk of ADHD.
METHODS: We conducted a population-based retrospective cohort study of children born in Manitoba, Canada, between 1998 and 2017 and their mothers. We defined exposure as the mother having filled 1 or more antibiotic prescriptions during pregnancy. The outcome was diagnosis of ADHD in the offspring, as identified in administrative databases. We estimated hazard ratios (HRs) using Cox proportional hazards regression in the overall cohort, in a separate cohort matched on high-dimensional propensity scores and in a sibling cohort.
RESULTS: In the overall cohort, consisting of 187 605 children, prenatal antibiotic dispensation was associated with increased risk of ADHD (HR 1.22, 95% confidence interval [CI] 1.18-1.26). Similar results were observed in the matched cohort of 129 674 children (HR 1.20, 95% CI 1.15-1.24) but not in the sibling cohort (HR 1.06, 95% CI 0.99-1.13). Two negative-control analyses indicated a positive association with ADHD despite the lack of a reasonable biological mechanism, which suggested that the observed association between prenatal antibiotic dispensation and risk of ADHD was likely due to confounding.
INTERPRETATION: In our study, prenatal antibiotic exposure was not associated with increased risk of ADHD in children. Although the risk was higher in the overall and matched cohorts, it was likely overestimated because of unmeasured confounding. Future studies are warranted to examine other factors affecting microbiota composition in association with risk of ADHD.
© 2020 Joule Inc. or its licensors.

Entities:  

Year:  2020        PMID: 32575031      PMCID: PMC7241887          DOI: 10.1503/cmaj.190883

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  36 in total

1.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

Review 2.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

Authors:  Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

3.  Learning from the census: the Socio-economic Factor Index (SEFI) and health outcomes in Manitoba.

Authors:  Dan Chateau; Colleen Metge; Heather Prior; Ruth-Ann Soodeen
Journal:  Can J Public Health       Date:  2012-07-04

4.  The placenta harbors a unique microbiome.

Authors:  Kjersti Aagaard; Jun Ma; Kathleen M Antony; Radhika Ganu; Joseph Petrosino; James Versalovic
Journal:  Sci Transl Med       Date:  2014-05-21       Impact factor: 17.956

5.  Long-Term Functional Outcomes in Israeli Adults Diagnosed in Childhood with Attention Deficit Hyperactivity Disorder.

Authors:  Lutfi Jaber; Dafna Kirsh; Gary Diamond; Avinoam Shuper
Journal:  Isr Med Assoc J       Date:  2015-08       Impact factor: 0.892

6.  Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study.

Authors:  Zheng Chang; Paul Lichtenstein; Brian M D'Onofrio; Catarina Almqvist; Ralf Kuja-Halkola; Arvid Sjölander; Henrik Larsson
Journal:  Int J Epidemiol       Date:  2014-10-29       Impact factor: 7.196

7.  Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system.

Authors:  C C Clements; V M Castro; S R Blumenthal; H R Rosenfield; S N Murphy; M Fava; J L Erb; S E Churchill; A J Kaimal; A E Doyle; E B Robinson; J W Smoller; I S Kohane; R H Perlis
Journal:  Mol Psychiatry       Date:  2014-08-26       Impact factor: 15.992

8.  Attention Deficit Hyperactivity Disorder Symptoms, Comorbidities, Substance Use, and Social Outcomes among Men and Women in a Canadian Sample.

Authors:  Evelyn Vingilis; Patricia G Erickson; Maggie E Toplak; Nathan J Kolla; Robert E Mann; Jane Seeley; Mark vanderMaas; Deanne S Daigle
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

9.  Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years.

Authors:  John M D Thompson; Karen E Waldie; Clare R Wall; Rinky Murphy; Edwin A Mitchell
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

Review 10.  The contribution of the gut microbiome to neurodevelopment and neuropsychiatric disorders.

Authors:  Barbara B Warner
Journal:  Pediatr Res       Date:  2018-09-25       Impact factor: 3.756

View more
  3 in total

Review 1.  Prenatal risk factors and genetic causes of ADHD in children.

Authors:  Naghmeh Kian; Noosha Samieefar; Nima Rezaei
Journal:  World J Pediatr       Date:  2022-03-02       Impact factor: 2.764

2.  Data Resource Profile: The Manitoba Multigenerational Cohort.

Authors:  Amani F Hamad; Randy Walld; Lisa M Lix; Marcelo L Urquia; Leslie L Roos; Elizabeth Wall-Wieler
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

3.  The Effect of Long-Term or Repeated Use of Antibiotics in Children and Adolescents on Cognitive Impairment in Middle-Aged and Older Person(s) Adults: A Cohort Study.

Authors:  Zhou Liu; Shouchao Wei; Xiaoxia Chen; Lingying Liu; Zhuangsheng Wei; Zhimin Liao; Jiayuan Wu; Zhichao Li; Haihong Zhou; Duolao Wang
Journal:  Front Aging Neurosci       Date:  2022-03-23       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.